The Council for Responsible Nutrition this week came out in support of the Food and Drug Administration taking action against marketing bulk pure powdered caffeine to consumers and its issuance of warning letters to five powdered caffeine distributors.
The findings from a study published in this month’s issue of Clinical Infectious Diseases tout the effectiveness of HIV pre-exposure prophylaxis (PrEP), marketed as Truvada (tenofovir/embtricitabine) medication.
AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.
Ancino this week launched its rivastigmine patch, a generic version of the Exelon patch.
Retail analytic company RetailNext on Friday announced its monthly Retail Performance Pulse, showing a 7.3% year-over-year decrease in sales and a 9.9% decline in traffic at physical stores for August.
Pfizer said that the transaction has strengthened the company’s branded and generics portfolio, particularly when it comes to biosimilars.
Nature’s Truth’s 10,000-mcg sublingual B-12 liquid is bringing consumers a high potency and fast-acting dose of vitamin B-12.
Stephen Colbert, who is gearing up to host his first "The Late Show" on Tuesday, is the new voice of Waze.
With consumer demand looking for a more natural approach to wellness, Nature’s Truth, the recently launched wholesale brand of Piping Rock Products, has introduced its Aromatherapy line of 15 Premium Essential Oils, to support healthy lifestyle needs.
Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta.